NewAmsterdam Pharma Company NV
NAMSW10.410USD
0.000
取引時間 （ET）15分遅れの株価
0.00時価総額
--直近12ヶ月PER
詳細情報 NewAmsterdam Pharma Company NV 企業名
NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.
企業情報
企業コードNAMSW
会社名NewAmsterdam Pharma Company NV
上場日Nov 23, 2022
最高経営責任者「CEO」Dr. Michael Harvey Davidson, M.D.
従業員数- -
証券種類Company Warrant
決算期末- -
本社所在地Gooimeer 2-35
都市NAARDEN
証券取引所NASDAQ Global Market Consolidated
国Netherlands
郵便番号1411 DC
電話番号31352062971
ウェブサイトhttps://ir.newamsterdampharma.com/
企業コードNAMSW
上場日Nov 23, 2022
最高経営責任者「CEO」Dr. Michael Harvey Davidson, M.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Director
Independent Director
--
--
Mr. Wouter Joustra
Mr. Wouter Joustra
Independent Director
Independent Director
--
--
Ms. Adele M. Gulfo
Ms. Adele M. Gulfo
Independent Director
Independent Director
--
--
Dr. Louis Lange, M.D., Ph.D.
Dr. Louis Lange, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Janneke Van Der Kamp
Ms. Janneke Van Der Kamp
Temporary Non-Executive Director
Temporary Non-Executive Director
--
--
Dr. James N. Topper, M.D., Ph.D.
Dr. James N. Topper, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Nicholas Downing, M.D.
Dr. Nicholas Downing, M.D.
Director
Director
--
--
Ms. Louise Kooij
Ms. Louise Kooij
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Michael Harvey Davidson, M.D.
Dr. Michael Harvey Davidson, M.D.
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Director
Independent Director
--
--
Mr. Wouter Joustra
Mr. Wouter Joustra
Independent Director
Independent Director
--
--
Ms. Adele M. Gulfo
Ms. Adele M. Gulfo
Independent Director
Independent Director
--
--
Dr. Louis Lange, M.D., Ph.D.
Dr. Louis Lange, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Janneke Van Der Kamp
Ms. Janneke Van Der Kamp
Temporary Non-Executive Director
Temporary Non-Executive Director
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Sat, Jul 5
更新時刻: Sat, Jul 5
株主統計
種類
株主統計
株主統計
比率
Other
100.00%
株主統計
株主統計
比率
Other
100.00%
種類
株主統計
比率
Other
100.00%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
26
1.31M
0.00%
-654.24K
2025Q1
28
1.31M
0.00%
-682.10K
2024Q4
31
1.32M
0.00%
-986.85K
2024Q3
38
1.33M
0.00%
-1.41M
2024Q2
50
1.30M
0.00%
-1.97M
2024Q1
49
1.44M
0.00%
-1.61M
2023Q4
46
1.64M
0.00%
-1.32M
2023Q3
45
1.61M
0.00%
-1.70M
2023Q2
45
1.95M
0.00%
-1.68M
2023Q1
44
2.30M
0.00%
-1.32M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Frazier Life Sciences Management, L.P.
500.33K
0%
--
--
Mar 31, 2025
RA Capital Management, LP
333.33K
0%
--
--
Mar 31, 2025
Affinity Asset Advisors LLC
241.96K
0%
+4.02K
+1.69%
Mar 31, 2025
Bain Capital Life Sciences Investors, LLC
100.00K
0%
--
--
Mar 31, 2025
Deerfield Management Company, L.P.
92.79K
0%
--
--
Mar 31, 2025
Laurion Capital Management LP
16.67K
0%
--
--
Mar 31, 2025
HRT Financial LP
--
0%
-13.65K
-100.00%
Mar 31, 2025
Wolverine Asset Management, LLC
8.88K
0%
-3.81K
-30.01%
Mar 31, 2025
Vestcor Inc
9.63K
0%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
2.38K
0%
-100.00
-4.03%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
